CCA
PRAH

Childress Capital Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Childress Capital Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-29
Closed -$4K – 1077
2020
Q4 		$4K Buy
+29
New +$3.24K ﹤0.01% 862

Other funds holding PRAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Childress Capital Advisors's PRAH Position: Q1 2021 in Review

Childress Capital Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 29 shares — an estimated $4K sold.

Childress Capital Advisors first reported a position in PRAH in Q4 2020 and held it in 1 quarter. The position peaked at $4K in Q4 2020. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • Childress Capital Advisors reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Childress Capital Advisors sold 29 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $4K.
  • Childress Capital Advisors first reported a position in PRA Health Sciences, Inc. in Q4 2020 and held it in 1 quarter.
  • Childress Capital Advisors's PRA Health Sciences, Inc. position peaked at $4K in Q4 2020.
  • 324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Childress Capital Advisors's 13F filing for Q1 2021, filed 21 May 2021.